LRBA mutations cause autoimmunity, lymphoproliferation and humoral immuneÊdeficiency. We describe a patient affected, since the age of 6 months, by autoimmunity/ autoinflammation including: panniculitis, evolved in gene- ralized lipodystrophy, hypertriglyceridemia, hyperglycemia, diffuse lymphadenopathy, hepatomegaly with hepatic steatosis, splenomegaly, autoimmune neutropenia, hypo- gammaglobulinemia and periodic fever. Exome sequencing revealed two novel heterozygous mutations in LRBA gene. She showed increased CD4:CD8 ratio with elevated memory T cells. Ki67 was increased in CD3, memory CD4 and double negative T cells. FOXP3+ T regulatory cells (Tregs) were present but decreased. LRBA expression was reduced, espe- cially on CD4+ T cells. Levels of CTLA4 in Tregs and the kinetic of its expression in activated T cells were altered with slower upregulation as compared to normal donors and faster downregulation, likely contributing to lymphoproliferation. Autoreactive CD21lowCD38low and activated CD24brightCD38low B cells were high, while memory B cells were reduced, supporting autoimmune manifestations and hypogammaglobuliemia. Rapamycin dramatically re- duced lymphoproliferation although a more targeted therapy would be desirable. Leptin treatment solved the atypical met- abolic manifestations whose cause remains unclear.

Lipopolysaccharide-responsive and beige-like anchor (LRBA) protein deficiency manifesting with lypodistrophy and alps-like phenotype treated with leptin and rapamycin / Barzaghi, Federica; Passerini, Laura; Sartirana, Claudia; Bejerano, Gill; Floris, Matteo; Cesaro, Simone; Cimaz, Rolando; Grazia Roncarolo, Maria; Santini, Ferruccio; Goldbach-Mansky, Raphaela; Aiuti, Alessandro; Bacchetta, Rosa. - In: JOURNAL OF CLINICAL IMMUNOLOGY. - ISSN 1573-2592. - 36:3(2016), pp. 293-293. [10.1007/s10875-016-0237-x]

Lipopolysaccharide-responsive and beige-like anchor (LRBA) protein deficiency manifesting with lypodistrophy and alps-like phenotype treated with leptin and rapamycin

Matteo Floris
Data Curation
;
2016-01-01

Abstract

LRBA mutations cause autoimmunity, lymphoproliferation and humoral immuneÊdeficiency. We describe a patient affected, since the age of 6 months, by autoimmunity/ autoinflammation including: panniculitis, evolved in gene- ralized lipodystrophy, hypertriglyceridemia, hyperglycemia, diffuse lymphadenopathy, hepatomegaly with hepatic steatosis, splenomegaly, autoimmune neutropenia, hypo- gammaglobulinemia and periodic fever. Exome sequencing revealed two novel heterozygous mutations in LRBA gene. She showed increased CD4:CD8 ratio with elevated memory T cells. Ki67 was increased in CD3, memory CD4 and double negative T cells. FOXP3+ T regulatory cells (Tregs) were present but decreased. LRBA expression was reduced, espe- cially on CD4+ T cells. Levels of CTLA4 in Tregs and the kinetic of its expression in activated T cells were altered with slower upregulation as compared to normal donors and faster downregulation, likely contributing to lymphoproliferation. Autoreactive CD21lowCD38low and activated CD24brightCD38low B cells were high, while memory B cells were reduced, supporting autoimmune manifestations and hypogammaglobuliemia. Rapamycin dramatically re- duced lymphoproliferation although a more targeted therapy would be desirable. Leptin treatment solved the atypical met- abolic manifestations whose cause remains unclear.
2016
Lipopolysaccharide-responsive and beige-like anchor (LRBA) protein deficiency manifesting with lypodistrophy and alps-like phenotype treated with leptin and rapamycin / Barzaghi, Federica; Passerini, Laura; Sartirana, Claudia; Bejerano, Gill; Floris, Matteo; Cesaro, Simone; Cimaz, Rolando; Grazia Roncarolo, Maria; Santini, Ferruccio; Goldbach-Mansky, Raphaela; Aiuti, Alessandro; Bacchetta, Rosa. - In: JOURNAL OF CLINICAL IMMUNOLOGY. - ISSN 1573-2592. - 36:3(2016), pp. 293-293. [10.1007/s10875-016-0237-x]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/203240
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact